Clinical Trials Browser

Phase 2/3 × Pancreatic Neoplasms × Oxaliplatin × Clear all

NCT02919787 2024-11-20

Nordic Pancreatic Cancer Trial (NorPACT) - 1

Phase 2/3 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT02172976 2020-09-02

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

Phase 2/3 Completed

Gastrointestinal

Pancreatic Neoplasms